Archive
All News
Every briefing, headline, and filing we've published, newest first.
PipelineFierceBiotech ↗
An FDA expert panel on Thursday voted 6 to 3 against AstraZeneca's proposal of using its oral SERD camizestran…
PipelineBriefing
FDA authorizes Auvelity for agitation tied to Alzheimer’s disease, positioning Axsome’s NMDA/sigma-1 modulator…
PipelineBioPharma Dive ↗
Known as Veppanu, the drug is the first of its kind to get to market. But Arvinas and partner Pfizer are still…
MoneyBioPharma Dive ↗
The company is making up for a decline in U.S. vaccine sales with better results elsewhere, continuing a turna…
![<![CDATA[CAQH Index Finds $20 Billion in Cost Savings Opportunities]]>](https://images.builtfor.ai/images/article-images/cdata-caqh-index-finds-20-billion-in-cost-savings-opportunit.jpg)
MoneyEndpoints News ↗
A trio of biotechs priced their IPOs on Thursday into Friday morning, setting the stage for their public tradi…
MoneyFiercePharma ↗
As Eli Lilly gets off to the races with the launch of its flagship oral GLP-1 Foundayo, the Indianapolis drugm…
DealsFierceBiotech ↗
Teva Pharmaceuticals has struck a deal to buy Emalex Biosciences for $700 million upfront, positioning the dru…
DealsBriefing
AstraZeneca resumes its shelved £300M UK expansion after rebate relief and a U.S.-U.K. pharma pact, signaling …
PipelineFiercePharma ↗
The FDA has released briefing documents detailing its concerns for AstraZeneca’s cancer drugs camizestrant and…
DealsFierceBiotech ↗
AbbVie has agreed to help finance a KRAS inhibitor from Kestrel Therapeutics in a deal that could hit up to $1…
PolicyBriefing
A judge approved Purdue Pharma’s criminal sentence, clearing the way for the company’s dissolution after years…
MoneyDrug Channels ↗
Today’s guest post comes from Cindy Baksh, Chief Product Officer at ConnectiveRx. Cindy explains that many gro…
PeopleSTAT News ↗
Examining the past statements and writings of Trump's third surgeon general nominee, Dr. Nicole Saphier, on va…
PipelineEndpoints News ↗
Bristol Myers Squibb’s cancer drug Krazati has failed its confirmatory study in second-line colorectal cancer,…
PolicyEndpoints News ↗
A powerful spending committee in Congress wants the FDA to ban the use of clinical trial data from China in fu…
PolicyEndpoints News ↗
WASHINGTON — Supreme Court justices gave a few hints about how they intend to rule in a divisive case for the …
PolicySTAT News ↗
FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's n…
MoneyEndpoints News ↗
Wall Street’s expectations for Bristol Myers Squibb’s upcoming slate of data readouts are reaching a fever pit…
PolicySTAT News ↗
ACA membership is tumbling after Congress failed to extend extra subsidies that helped people afford the cover…
DealsPharmaVoice ↗
Settlements delaying the arrival of generic versions of tafamidis will protect billions in Pfizer revenue and …
PolicyKFF Health News ↗
This brief reviews current federal and state policies on Medicaid and insurance coverage of abortion services …
DealsPharmaceutical Technology ↗
Chiesi will assume ownership of Ekterly, an on-demand pill approved for hereditary angioedema.…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.